Charles River Laboratories International (CRL) Change in Inventory (2009 - 2026)
Charles River Laboratories International (CRL) posted Change in Inventory of -$17.7 million for Q2 2026, up 31.77% on a QoQ basis from -$26.0 million in Q1 2026, and down 123.77% year-over-year from $74.6 million in Q2 2025.
Analysis
Charles River Laboratories International (CRL) Change in Inventory (2009 - 2026) Analysis & Trends
Charles River Laboratories International has reported Change in Inventory for 18 years, with the latest figure at -$17.7 million in Q2 2026.
- On a quarterly basis, Change in Inventory fell 123.77% year-over-year to -$17.7 million in Q2 2026; TTM through Jun 2026 was -$8.9 million, a 229.34% decrease from a year earlier, with the FY2025 full-year figure at $48.8 million, up 390.27% from the prior year.
- Change in Inventory was -$17.7 million for Q2 2026 at Charles River Laboratories International, up from -$26.0 million in the prior quarter.
- The five-year high for Change in Inventory was $40.6 million in Q2 2022, with the low at -$26.0 million in Q1 2026.
- Average Change in Inventory over 5 years is $7.2 million, with a median of $6.0 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2026: Change in Inventory jumped 1043.94% in 2022, then plunged 218.84% in 2026.
- Over 5 years, Change in Inventory stood at $2.2 million in 2022, then surged by 711.38% to $18.2 million in 2023, then tumbled by 116.59% to -$3.0 million in 2024, then soared by 215.99% to $3.5 million in 2025, then tumbled by 607.38% to -$17.7 million in 2026.
- The last three Change in Inventory figures came in at -$17.7 million (Q2 2026), -$26.0 million (Q1 2026), and $3.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | - |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -17.74 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -85,346.93 |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | -17.74 Mn |
| Mar 28, 2026 | -26.00 Mn |
| Dec 27, 2025 | 3.50 Mn |
| Sep 27, 2025 | 31.33 Mn |
| Jun 28, 2025 | -7.93 Mn |
| Mar 29, 2025 | 21.88 Mn |
| Dec 28, 2024 | -3.02 Mn |
| Sep 28, 2024 | -4.04 Mn |
| Jun 29, 2024 | -4.15 Mn |
| Mar 30, 2024 | -5.60 Mn |
| Dec 30, 2023 | 18.18 Mn |
| Sep 30, 2023 | 11.46 Mn |
| Jul 1, 2023 | 24.08 Mn |
| Apr 1, 2023 | 8.59 Mn |
| Dec 31, 2022 | 2.24 Mn |
| Sep 24, 2022 | 12.56 Mn |
| Jun 25, 2022 | 40.56 Mn |
| Mar 26, 2022 | 23.16 Mn |
| Dec 25, 2021 | 19.52 Mn |
| Sep 25, 2021 | -1.47 Mn |